Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance

Valesca P. Retel, Manuela A. Joore, Wim H. van Harten*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)627-636
JournalBreast Cancer Research and Treatment
Issue number2
Publication statusPublished - Jan 2012


  • Head-to-head comparison
  • 70-gene signature
  • MammaPrint
  • 21-gene recurrence score
  • Oncotype DX
  • Cost-effectiveness analysis

Cite this